Healio Blog Update: Optimizing donor selection in aplastic anemia — evolving trends in transplantation
In a new Healio blog post, Dr. Omar Aljitawi explores how donor selection for patients with severe aplastic anemia is evolving, with improved outcomes seen in both haploidentical and umbilical cord blood transplants. With advancements in post-transplant cyclophosphamide and conditioning regimens, the field may be moving toward a more personalized approach to donor choice.
“I think ‘donor choice’ for patients with aplastic anemia might become an area of focus for personalized medicine.”
— Omar Aljitawi, MBBS